Converting enzyme inhibition and modulation of plasma renin activity with captopril in anesthetized rats

M. Suzuki, S. Satoh

研究成果: Article

3 引用 (Scopus)

抜粋

We examined the effects of an orally active inhibitor of converting enzyme, captopril (D-3-mercapto-2-methylpropanoyl-L-proline), in pentobarbital-anesthetized rats. Intravenous (i.v.) administration of captopril (0.1, 0.3, 1.0, 3.0 mg/kg) resulted in a dose-dependent inhibition of the pressor responses to angiotensin I (1.0 μg/kg, i.v.); at 1.0 mg/kg, captopril markedly potentiated the magnitude and duration of vasodepressor responses elicited by bradykinin (0.3 μg/kg, i.v.). Captopril effected a marked elevation of plasma renin activity by its blocking action on the angiotensin II-mediated negative feedback of renin release without markedly altering systemic blood pressure and heart rate. Propranolol (1.5 mg/kg, i.v.), at a dose which almost completely inhibited isoproterenol (0.15 μg/kg/min, i.a.)-induced renin release, tended to suppress the captopril-induced renin release. However, indomethacin (5.0 mg/kg, i.v.) failed to change the captopril-induced renin release. These findings suggest that captopril specifically inhibits converting enzyme and kininase II, and that captopril-induced renin release is partially associated with the beta-adrenergic system without mediation by prostaglandins.

元の言語English
ページ(範囲)121-136
ページ数16
ジャーナルArchives Internationales de Pharmacodynamie et de Therapie
253
発行部数1
出版物ステータスPublished - 1981 12 1

ASJC Scopus subject areas

  • Pharmacology

フィンガープリント Converting enzyme inhibition and modulation of plasma renin activity with captopril in anesthetized rats' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用